NOVEL POLYMER DERIVATIVE OF CYTIDINE METABOLISM ANTAGONIST
[Problem] To provide a novel polymer derivative of a cytidine metabolic antagonist which allows release of a medicament irrespective of enzymes of the living body and is expected to have high therapeutic effects. [Solution] The polymer derivative of a cytidine metabolic antagonist in which a substit...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English Korean |
Published |
03.03.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | [Problem] To provide a novel polymer derivative of a cytidine metabolic antagonist which allows release of a medicament irrespective of enzymes of the living body and is expected to have high therapeutic effects. [Solution] The polymer derivative of a cytidine metabolic antagonist in which a substituent represented by the general formula (I) or the general formula (II) [wherein R 7 and R 8 each independently represent a hydrogen atom or an optionally substituted (C1-C6)alkyl group, R 6 represents a hydrogen atom, an optionally substituted (C1-C40)alkyl group, an optionally substituted (C1-C40)aralkyl group, an optionally substituted aromatic group, an amino acid residue in which the carboxy group is protected, or an optionally substituted sugar residue, CX-CY represents CH-CH or C=C (double bond), and A represents the residue of the cytidine metabolic antagonist except the amino group at the position 4] is bonded to the side-chain carboxy group of a block copolymer of a polyethylene-glycol structural moiety and a polymer having 10 or more carboxy groups. |
---|---|
Bibliography: | Application Number: KR20137011461 |